tm
Seeing Is Believing
tm
Seeing Is Believing
Currently out of the existing stock ratings of Thomas Smith, 61 are a BUY (73.49%), 22 are a HOLD (26.51%).
Analyst Thomas Smith, carries an average stock price target met ratio of 45.12% that have a potential upside of 42.06% achieved within 126 days. Previously, Thomas Smith worked at LEERINK.
Thomas Smith’s has documented 154 price targets and ratings displayed on 28 stocks. The coverage was on Healthcare, Industrials sectors.
Most recent stock forecast was given on RAPT, RAPT Therapeutics at 26-Sep-2025.
Analyst best performing recommendations are on AXLA (AXCELLA HEALTH).
The best stock recommendation documented was for AXLA (AXCELLA HEALTH) at 12/15/2022. The price target of $6 was fulfilled within 1 day with a profit of $4.98 (45.36%) receiving and performance score of 453.55.
Average potential price target upside
Analyst name
Rating
Current price target
Potential Upside
Previous price target
Date
Price targets met ratio
Average potential upside
Average Time (Days) For PT To Be Met
Performance score
Buy
$3
$1.79 (147.93%)
$3
1 years 9 days ago
(26-Sep-2024)
0/4 (0%)
$2.42 (417.24%)
Hold
$7
1 years 3 months 15 days ago
(20-Jun-2024)
1/3 (33.33%)
$0.45 (6.87%)
57
Sell
$1
$-0.21 (-17.36%)
$1.5
1 years 8 months 18 days ago
(17-Jan-2024)
6/6 (100%)
$-0.02 (-1.96%)
278
Buy
1 years 9 months 17 days ago
(18-Dec-2023)
1/1 (100%)
$32.69 (83.16%)
358
Buy
$9
$7.79 (643.80%)
2 years 4 months 24 days ago
(11-May-2023)
2/4 (50%)
$4.84 (116.35%)
178
Which stock is Thomas Smith is most bullish on?
What Year was the first public recommendation made by Thomas Smith?
